BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22233329)

  • 1. The pathology and clinical features of early recurrent membranous glomerulonephritis.
    Rodriguez EF; Cosio FG; Nasr SH; Sethi S; Fidler ME; Stegall MD; Grande JP; Fervenza FC; Cornell LD
    Am J Transplant; 2012 Apr; 12(4):1029-38. PubMed ID: 22233329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients.
    Morales JM; Pascual-Capdevila J; Campistol JM; Fernandez-Zatarain G; Muñoz MA; Andres A; Praga M; Martinez MA; Usera G; Fuertes A; Oppenheimer F; Artal P; Darnell A; Rodicio JL
    Transplantation; 1997 Jun; 63(11):1634-9. PubMed ID: 9197359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
    Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
    Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological analysis of allogeneic hematopoietic stem cell transplantation-related membranous glomerulonephritis.
    Hiramatsu R; Ubara Y; Sawa N; Hasegawa E; Kawada M; Imafuku A; Sumida K; Mise K; Yamanouchi M; Ueno T; Sekine A; Hayami N; Suwabe T; Hoshino J; Takaichi K; Ohashi K; Fujii T; Wake A; Taniguchi S
    Hum Pathol; 2016 Apr; 50():187-94. PubMed ID: 26997455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation.
    Sprangers B; Lefkowitz GI; Cohen SD; Stokes MB; Valeri A; Appel GB; Kunis CL
    Clin J Am Soc Nephrol; 2010 May; 5(5):790-7. PubMed ID: 20185599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological study of de novo membranous nephropathy of 'stage 0' after kidney transplantation.
    Katsuma A; Nakada Y; Yamamoto I; Horita S; Katsumata H; Kobayashi A; Unagami K; Okumi M; Ishida H; Yokoo T; Yamaguchi Y; Tanabe K;
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():63-69. PubMed ID: 29968407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts.
    Monga G; Mazzucco G; Basolo B; Quaranta S; Motta M; Segoloni G; Amoroso A
    Mod Pathol; 1993 May; 6(3):249-58. PubMed ID: 8346172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study.
    Dabade TS; Grande JP; Norby SM; Fervenza FC; Cosio FG
    Am J Transplant; 2008 Jun; 8(6):1318-22. PubMed ID: 18444918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis.
    Hoxha E; Harendza S; Zahner G; Panzer U; Steinmetz O; Fechner K; Helmchen U; Stahl RA
    Nephrol Dial Transplant; 2011 Aug; 26(8):2526-32. PubMed ID: 21633097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous nephropathy with crescents: a series of 19 cases.
    Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
    Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease.
    Jindal N; Yadav D; Passero C; Krasinskas A; Craig F; Bastacky S; Liang KV
    Clin Nephrol; 2012 Apr; 77(4):321-8. PubMed ID: 22445476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membranous glomerulonephritis with crescents.
    Barrett CM; Troxell ML; Larsen CP; Houghton DC
    Int Urol Nephrol; 2014 May; 46(5):963-71. PubMed ID: 24217802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies.
    El-Zoghby ZM; Grande JP; Fraile MG; Norby SM; Fervenza FC; Cosio FG
    Am J Transplant; 2009 Dec; 9(12):2800-7. PubMed ID: 19845581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib as a Novel Approach to Early Recurrent Membranous Glomerulonephritis After Kidney Transplant Refractory to Combined Conventional Rituximab Therapy.
    Barbari A; Chehadi R; Kfoury Assouf H; Kamel G; Jaafar M; Abdallah A; Rizk S; Masri M
    Exp Clin Transplant; 2017 Jun; 15(3):350-354. PubMed ID: 28367758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo proliferative glomerulonephritis with monoclonal IgG deposits of the IgG1κ subtype in a kidney allograft.
    Tsuji T; Miura M; Yanai M; Itami H; Ishii Y; Akimoto M; Fukasawa Y
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():44-7. PubMed ID: 26976360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts.
    Kearney N; Podolak J; Matsumura L; Houghton D; Troxell M
    Transplant Proc; 2011 Dec; 43(10):3743-6. PubMed ID: 22172838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients.
    Segarra A; Praga M; Ramos N; Polanco N; Cargol I; Gutierrez-Solis E; Gomez MR; Montoro B; Camps J
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1083-8. PubMed ID: 19478097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare cause of proteinuria after kidney transplantation: Answers.
    Göknar N; Saygılı S; Canpolat N; Özlük Y; Kılıçaslan I; Sever L; Çalışkan S
    Pediatr Nephrol; 2019 Nov; 34(11):2333-2335. PubMed ID: 31041519
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal pathology in hematopoietic cell transplantation recipients.
    Troxell ML; Pilapil M; Miklos DB; Higgins JP; Kambham N
    Mod Pathol; 2008 Apr; 21(4):396-406. PubMed ID: 18223556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.